022 24172311
Sections
Search
DealCurry
Equity
Venture Capital
Private Equity
M&A

Banner
DataBoard Demo
Capital Market | 11 January 2013

After Macquarie, Jeremy Grantham's GMO Fund Sells Stake In Sintex Ind.

by Vivek Singh
After Macquarie, Jeremy Grantham's GMO Fund Sells Stake In Sintex Ind.
Share on Social Media Email Facebook Twitter Linkedin
 
@vivek
Grantham GMO Emerging Markets, the global investment manager headed by Jeremy Grantham, sold over 15.04 lakh shares of Sintex Industries through bulk deal on NSE.

The fund manager sold the shares for R69.25 per piece aggregating to R10.42 Cr.

Latest shareholding showed GMO Emerging Markets Fund holding 2.29% stake or over 71.64 lakh shares.

IDFC Midcap Fund Acquires Stake In Innoventive Industries

IDFC Midcap Fund Acquires Stake In Innoventive Industries

IDFC Small And Midcap Fund has acquired around 3.4% stake in Innoventive Industries for R28 Cr.

Read More...

Clinical-stage specialty bio-pharmaceutical company Vyome Biosciences raises $14 million

Clinical-stage specialty bio-pharmaceutical company Vyome Biosciences raises $14 million

The clinical-stage specialty bio-pharmaceutical company Vyome Biosciences Private Limited has raises $14 million in Series-C financing round. The financing round was led by a prominent New York based life sciences fund Perceptive Advisors. Apart from that the funding round saw participation of a Boston-based venture capital Romulus Capital along with existing investors.

Read More...
Subscribe
Enter your Email address
to receive all the news